comparemela.com
Home
Live Updates
New Data from Phase 3 Trial Further Validate Prognostic Value of Veracytes Decipher Prostate Genomic Classifier : comparemela.com
New Data from Phase 3 Trial Further Validate Prognostic Value of Veracyte's Decipher Prostate Genomic Classifier
Findings presented at the 2023 ASTRO Annual Meeting expand substantial body of evidence demonstrating Decipher Prostate test’s ability to help inform prostate cancer treatment...
Related Keywords
California
,
United States
,
South San Francisco
,
Vincentk Smith
,
Phuoct Tran
,
Elai Davicioni
,
Daniel Spratt
,
Twitter
,
American Society For Radiation Oncology
,
University Of Maryland School Medicine
,
Veracyte Inc
,
Nasdaq
,
Decipher Prostate Genomic Classifier
,
Radiation Oncology
,
Annual Meeting
,
Decipher Prostate
,
Maryland School
,
University Hospitals Seidman Cancer Center
,
Case Western Reserve University School
,
Annual Report
,
Quarterly Report
,
Markets
,
comparemela.com © 2020. All Rights Reserved.